Evidence map›Paper›PMID 37020484›Full record

ArticleCureus2023

The Prevalence of Cardiovascular Manifestations in Pediatric Sickle Cell Anemia Patients in a Large Tertiary Care Hospital in the Western Region of Saudi Arabia.

Rahaf Waggass, Abeer K Alhindi, Inas S Bagabas, Mawaddah H Alsaegh, Noor K Alsharef, Roaa E Morya, Muhammad A Khan, Wasil Jastaniah

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Rahaf WaggassPediatric Cardiology, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Abeer K AlhindiMedicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Inas S BagabasMedicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Mawaddah H AlsaeghMedicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Noor K AlsharefMedicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Roaa E MoryaMedicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Muhammad A KhanMedical Education, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Wasil JastaniahOncology, King Faisal Specialist Hospital and Research Centre, Jeddah, SAU.
King Abdullah International Medical Research Center · SAKing Abdulaziz Medical City · SAKing Saud bin Abdulaziz University for Health Sciences · SAKing Faisal Specialist Hospital & Research Centre · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Sickle cell disease (SCD) is a common hematological disorder with a high prevalence in Saudi Arabia. Despite that, limited studies are available in our region regarding cardiovascular complications. Objectives The objective of the current study was to estimate the prevalence of cardiovascular complications among children with SCD. Design This was a cross-sectional study. Setting The study took place at a single tertiary-care center in Jeddah, Saudi Arabia. Materials and methods The study reviewed 126 electronic records of pediatric patients up to 16 years old diagnosed with SCD between January 2008 and December 2019 in King Abdulaziz Medical City (KAMC) in Jeddah, Saudi Arabia. Of these, 54 patients had a previous echocardiogram evaluation and were eligible for the study. Main outcomes measures The study identified cardiovascular complications in pediatric sickle cell patients. Sample size The study included a total of 54 pediatric sickle cell patients. Results The mean age was 11.9 (3.48) years, the male-to-female ratio was 2:1, the majority (94.4%) had the HbSS-HbSβ0 genotype, the mean baseline hemoglobin F (fetal hemoglobin) was 20.30 (9.03%), and the clinical severity score was severe in 19 (35.2%) and mild/moderate in 35 (64.8%) patients. Cardiovascular complications occurred in 32 (59.3%) patients. Increased systolic blood pressure was detected in 10 (18.5%) patients. Echocardiography showed left ventricular dilatation in nine (16.7%) patients, tricuspid valve insufficiency in six (11.1%) patients, mitral valve insufficiency in four (7.4%) patients, hyperdynamic left ventricle in one (1.9%) patient, and pulmonary hypertension in one (1.9%) patient. Long QTc interval was noticed in three (5.6%) and cardiomegaly was detected in 18 (33.3%) patients. Conclusion Cardiovascular complications occurred at a high frequency in our pediatric population despite high baseline hemoglobin F levels. Early evaluation and continuous monitoring are important for early intervention.

Indexed as

cardiovascular complicationschildrenhigh systolic blood pressurehyperdynamic left ventricleleft ventricular dilatationmitral valve insufficiencypulmonary hypertensionsaudi arabiasickle cell diseasetricuspid valve insufficiency

Identifiers

PMID37020484
PMCPMC10069165
OpenAlexW4323075582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.